CE Summit 2014

2014-12-06 - 2014-12-07
Ljubljana, Slovenia

AHA 2014

2014-11-15 - 2014-11-19
Chicago, United States

ESC 2014

2014-08-30 - 2014-09-03
Barcelona, Spain
Search in Scientific Content:
Date
Filters:
Effectiven
4:27

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

Presenter: Steven B. Deitelzweig
ACC 2021
PRADA Tria
4:48

PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol

Presenter: Siri Lagethon Heck
ACC 2021
ADAPTABLE
5:09

ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial

Presenter: William Schuyler Jones
ACC 2021
PARADISE-M
6:09

PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction

Presenter: Marc A. Pfeffer
ACC 2021
Inspiratio
7:46

Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19

Presenter: Behnood Bikdeli
ACC 2021
Core Knowl
11:14

Core Knowledge in Action: The Ultimate Guide to Lipids

Presenter: Eugene Yang
ACC 2021
Evolocumab
6:00

Evolocumab use in patients with human immunodeficiency virus and dyslipidemia

Presenter: Franck Boccara
ACC 2021
Tailor-Pci
10:37

Tailor-Pci Randomized Clinical Trial Follow-up Study: Effect Of Genotype-guided Oral P2y12 Inhibitors Vs Conventional Clopidogrel On Long-term Ischemic Outcomes After Percutaneous Coronary Intervention

Presenter: Naveen L. Pereira
ACC 2021
Results Fr
7:29

Results From the Twilight Study: Sex-Specific Outcomes In High-Risk Patients Receiving Ticagrelor With Or Without Aspirin After Percutaneous Coronary Intervention

Presenter: Birgit Vogel
ACC 2021
VOYAGER PA
7:53

VOYAGER PAD Trial: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization

Presenter: Rupert Bauersachs
ACC 2021
Aspirin Vs
7:13

Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention

Presenter: Hyo-Soo Kim
ACC 2021
Effects Of
8:19

Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers Of Inflammation Among Patients At High Risk For Atherosclerotic Events

Presenter: Paul M. Ridker
ACC 2021
ISCHEMIA T
8:06

ISCHEMIA Trial: Impact Of Completeness Of Revascularization On Clinical Outcomes In Patients With Stable Ischemic Heart Disease Treated With An Invasive Vs. Conservative Strategy

Presenter: Gregg Stone
ACC 2021
A Phase 2
6:54

A Phase 2 Trial Of The Efficacy And Safety Of Evinacumab In Patients With Severe Hypertriglyceridemia

Presenter: Robert Rosenson
ACC 2021
Hypertensi
15:49

Hypertension Guidelines: Do They Vary Across the World as Much as My Blood Pressure Has Today

Presenter: Paul Whelton
ACC 2021
STRENGTH T
3:43

STRENGTH Trial: Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk

Presenter: Steven E. Nissen
ACC 2021
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker